ConsiGma®
This standalone module allows you to start developing your PAT models for a pharmaceutical continuous manufacturing process offline during the early stages of R&D.
LightHouse Probe®
In a continuous manufacturing process, process analytical technology (PAT) tools are often used as an integral part of the control strategy. Model development can, however, be time-consuming.
The ConsiGma®PAT test rig allows customers to start PAT model development offline, long before the entire plant is installed, in a set-up similar to the production environment.
NIR probe and spectrometer
Read more about how GEA and its partners are implementing this technology to lead the way toward smaller, more flexible, continuous processing technologies that are transforming the future of pharmaceutical development and manufacturing.
An indispensable part of the ConsiGma 4.0 portfolio, the Conductor 4.0 control system architecture ensures smooth operation and communication between the different elements of a pharmaceutical continuous manufacturing line
The Lighthouse Probe® can be used for real-time monitoring of chemical and pharmaceutical processes and provides in-process window cleaning at any time, recalibration during the process, full CIP (cleaning) of wash housing and seal, and a clear view inside – even in difficult conditions.
The ConsiGma® TC modules are based on the GEA high-performance tablet coating technology that gently and accurately deposits controlled amounts of coating materials onto tablet cores — even if they are hygroscopic or friable.
The ConsiGma® GD 25/80 offers standalone continuous twin-screw granulation and drying for small-scale R&D operations. It allows users to develop the process and achieve high granule quality on a compact unit.
GEA 遠心分離機の歴史は、フランツ・ラメゾールとフランツ・シュミットが特許を取得した機械式ミルクセパレーターの生産を開始した1893年に始まり、これを機に近代的な乳製品加工への道が切り開かれることとなりました。この技術革新は、19世紀末のドイツで増え続ける都市人口にいかにミルクを供給するかという、当時の大きな課題を克服するのに役立ちました。そして、活況を呈する乳業業界に拍車をかけることにもなるのです。1913年までには、ドイツ国内で遠心分離...